stroke
BrainCool: “The clinical study could lead to new stroke treatment”
BrainCool and the University Hospital of Freiburg have initiated the pivotal Phase III clinical trial Cottis 2 combining target temperature management and thrombectomy...
BrainCool launches Cooral System next year
The American Medical Association has published a new code...
BrainCool about the FDA approval
BrainCool has received a so-called 510(k) approval...
BrainCool comments on the increased order intake
BrainCool's collaboration with the American ZOLL has received a...
BrainCool has many irons in the fire
In a recent studio interview with BioStock, BrainCools tells...
BrainCool comments on the agreement with the University of Maryland
BrainCool has entered into an agreement with the University of...
This is how BrainCool wants to create interest in the stroke industry
Significant clinical data from the EU-funded stroke study Cottis...
Medfield Diagnostics CEO on MD100 Strokefinder and the IPO
A quick and accurate diagnosis of stroke is...
BioStock Investor Pitch: Medfield Diagnostics
Medfield Diagnostics is a medical technology company that has developed the first...
Medfield Diagnostics wants to improve stroke diagnosis
Gothenburg-based Medfield Diagnostics has developed the MD100 Strokefinder, the market's...
Medfield Diagnostics on the issue and marketing efforts
The need for a rapid and accurate diagnosis of...
BrainCool's CEO on the purchasing agreement in the USA
BrainCool has signed a purchase agreement for IQool System...